COVID-19: Pfizer to produce vaccine component in Ireland
Pfizer is to begin producing vaccine component for its COVID-19 at an Irish facility for the first time.
The U.S. drugmaker said in a statement on Wednesday that, an existing Pfizer facility at Grange Castle in Dublin will produce mRNA drug substance with output to begin by the end of the year.
“Setting up production will cost $40 million and will employ 75 people.
“Given the extensive technical transfer process, on-site development, equipment installation and regulatory approvals needed for the site, we expect it will be brought onto the network by the end of 2021.”
Irish Prime Minister Micheal Martin welcomed the development as great news, that puts Ireland at the heart of the EU’s fight against the pandemic.
READ ALSO: Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccine
Kamila/Reuters
